{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:21:59Z","timestamp":1793647319893,"version":"4.5.1"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Oncode Accelerator, Grant reference Number; NGFOP2201"},{"DOI":"10.13039\/501100006244","name":"Stichting Kinderen Kankervrij","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006244","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-62673-2","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T09:03:30Z","timestamp":1755767010000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Small round cell sarcoma tumoroid biobank reveals CIC::DUX4 sarcoma vulnerability to MCL-1 inhibition"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0684-4613","authenticated-orcid":false,"given":"Femke C. A. S.","family":"Ringnalda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0572-3243","authenticated-orcid":false,"given":"Gijs J. F.","family":"van Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5556-0256","authenticated-orcid":false,"given":"Laurens H. G.","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8566-839X","authenticated-orcid":false,"given":"Seok-Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Amo-Addae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta E.","family":"Flucke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura S.","family":"Hiemcke\u2013Jiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin P. S.","family":"Langenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos A. M.","family":"Bramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotte","family":"Heimans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel A. J.","family":"van de Sande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winan J.","family":"van Houdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max M.","family":"van Noesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2289-4108","authenticated-orcid":false,"given":"Hinri H. D.","family":"Kerstens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4433-9797","authenticated-orcid":false,"given":"Marcel","family":"Santoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8730-2276","authenticated-orcid":false,"given":"Olivier","family":"Delattre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6114-9499","authenticated-orcid":false,"given":"Katia","family":"Scotlandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4361-3643","authenticated-orcid":false,"given":"Birgit","family":"Geoerger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7659-1028","authenticated-orcid":false,"given":"Johannes H. M.","family":"Merks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J.","family":"Molenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1285-2836","authenticated-orcid":false,"given":"Ruben","family":"van Boxtel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8195-9939","authenticated-orcid":false,"given":"Marc","family":"van de Wetering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9634-9853","authenticated-orcid":false,"given":"Karin","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3077-5582","authenticated-orcid":false,"given":"Hans","family":"Clevers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"62673_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.humpath.2024.01.007","volume":"147","author":"CA Dehner","year":"2024","unstructured":"Dehner, C. A., Lazar, A. J. & Chrisinger, J. S. A. Updates on WHO classification for small round cell tumors: Ewing sarcoma vs. everything else. Hum. Pathol. 147, 101\u2013113 (2024).","journal-title":"Hum. Pathol."},{"key":"62673_CR2","first-page":"759725","volume":"2013","author":"KA Ross","year":"2013","unstructured":"Ross, K. A., Smyth, N. A., Murawski, C. D. & Kennedy, J. G. The biology of Ewing sarcoma. ISRN Oncol. 2013, 759725 (2013).","journal-title":"ISRN Oncol."},{"key":"62673_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0165-4608(84)90003-7","volume":"12","author":"A Aurias","year":"1984","unstructured":"Aurias, A., Rimbaut, C., Buffe, D., Zucker, J. M. & Mazabraud, A. Translocation involving chromosome 22 in Ewing\u2019s sarcoma. A cytogenetic study of four fresh tumors. Cancer Genet. Cytogenet. 12, 21\u201325 (1984).","journal-title":"Cancer Genet. Cytogenet."},{"key":"62673_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/359162a0","volume":"359","author":"O Delattre","year":"1992","unstructured":"Delattre, O. et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359, 162\u2013165 (1992).","journal-title":"Nature"},{"key":"62673_CR5","first-page":"423","volume":"10","author":"SL Lessnick","year":"1995","unstructured":"Lessnick, S. L., Braun, B. S., Denny, C. T. & May, W. A. Multiple domains mediate transformation by the Ewing\u2019s sarcoma EWS\/FLI-1 fusion gene. Oncogene 10, 423\u2013431 (1995).","journal-title":"Oncogene"},{"key":"62673_CR6","doi-asserted-by":"publisher","first-page":"5752","DOI":"10.1073\/pnas.90.12.5752","volume":"90","author":"WA May","year":"1993","unstructured":"May, W. A. et al. Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc. Natl. Acad. Sci. USA 90, 5752\u20135756 (1993).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62673_CR7","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1093\/hmg\/ddl136","volume":"15","author":"M Kawamura-Saito","year":"2006","unstructured":"Kawamura-Saito, M. et al. Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation. Hum. Mol. Genet. 15, 2125\u20132137 (2006).","journal-title":"Hum. Mol. Genet."},{"key":"62673_CR8","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/cncy.21685","volume":"124","author":"I Chebib","year":"2016","unstructured":"Chebib, I. & Jo, V. Y. Round cell sarcoma with CIC-DUX4 gene fusion: discussion of the distinctive cytomorphologic, immunohistochemical, and molecular features in the differential diagnosis of round cell tumors. Cancer Cytopathol. 124, 350\u2013361 (2016).","journal-title":"Cancer Cytopathol."},{"key":"62673_CR9","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1172\/JCI126366","volume":"129","author":"RA Okimoto","year":"2019","unstructured":"Okimoto, R. A. et al. CIC-DUX4 oncoprotein drives sarcoma metastasis and tumorigenesis via distinct regulatory programs. J. Clin. Invest 129, 3401\u20133406 (2019).","journal-title":"J. Clin. Invest"},{"key":"62673_CR10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/modpathol.2014.139","volume":"28","author":"TL Peters","year":"2015","unstructured":"Peters, T. L. et al. BCOR-CCNB3 fusions are frequent in undifferentiated sarcomas of male children. Mod. Pathol. 28, 575\u2013586 (2015).","journal-title":"Mod. Pathol."},{"key":"62673_CR11","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1097\/PAS.0000000000000965","volume":"42","author":"YC Kao","year":"2018","unstructured":"Kao, Y. C. et al. BCOR-CCNB3 fusion positive sarcomas: a clinicopathologic and molecular analysis of 36 cases with comparison to morphologic spectrum and clinical behavior of other round cell sarcomas. Am. J. Surg. Pathol. 42, 604\u2013615 (2018).","journal-title":"Am. J. Surg. Pathol."},{"key":"62673_CR12","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1200\/JCO.19.00915","volume":"37","author":"U Dirksen","year":"2019","unstructured":"Dirksen, U. et al. High-dose chemotherapy compared with standard chemotherapy and lung radiation in ewing sarcoma with pulmonary metastases: results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008. J. Clin. Oncol. 37, 3192\u20133202 (2019).","journal-title":"J. Clin. Oncol."},{"key":"62673_CR13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fonc.2012.00054","volume":"2","author":"H Kovar","year":"2012","unstructured":"Kovar, H. et al. The first European interdisciplinary ewing sarcoma research summit. Front. Oncol. 2, 54 (2012).","journal-title":"Front. Oncol."},{"key":"62673_CR14","doi-asserted-by":"publisher","first-page":"7801","DOI":"10.1002\/cam4.5539","volume":"12","author":"M Brahmi","year":"2023","unstructured":"Brahmi, M. et al. Patterns of care and outcome of CIC-rearranged sarcoma patients: a nationwide study of the French sarcoma group. Cancer Med. 12, 7801\u20137807 (2023).","journal-title":"Cancer Med."},{"key":"62673_CR15","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1080\/0284186X.2021.1890818","volume":"60","author":"A Kyriazoglou","year":"2021","unstructured":"Kyriazoglou, A. & Bagos, P. Meta-analysis of BCOR rearranged sarcomas: challenging the therapeutic approach. Acta Oncol. 60, 721\u2013726 (2021).","journal-title":"Acta Oncol."},{"key":"62673_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48634-y","volume":"9","author":"P Nanni","year":"2019","unstructured":"Nanni, P. et al. Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations. Sci. Rep. 9, 12174 (2019).","journal-title":"Sci. Rep."},{"key":"62673_CR17","doi-asserted-by":"publisher","first-page":"111761","DOI":"10.1016\/j.celrep.2022.111761","volume":"41","author":"MF Orth","year":"2022","unstructured":"Orth, M. F. et al. Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulation. Cell Rep. 41, 111761 (2022).","journal-title":"Cell Rep."},{"key":"62673_CR18","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1053\/j.gastro.2011.07.050","volume":"141","author":"T Sato","year":"2011","unstructured":"Sato, T. et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett\u2019s epithelium. Gastroenterology 141, 1762\u20131772 (2011).","journal-title":"Gastroenterology"},{"key":"62673_CR19","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.stem.2024.08.010","volume":"31","author":"A Al Shihabi","year":"2024","unstructured":"Al Shihabi, A. et al. The landscape of drug sensitivity and resistance in sarcoma. Cell Stem Cell 31, 1524\u20131542.e1524 (2024).","journal-title":"Cell Stem Cell"},{"key":"62673_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15155-6","volume":"11","author":"C Calandrini","year":"2020","unstructured":"Calandrini, C. et al. An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity. Nat. Commun. 11, 1310 (2020).","journal-title":"Nat. Commun."},{"key":"62673_CR21","doi-asserted-by":"publisher","first-page":"e16001","DOI":"10.15252\/emmm.202216001","volume":"14","author":"MT Meister","year":"2022","unstructured":"Meister, M. T. et al. Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes. EMBO Mol. Med. 14, e16001 (2022).","journal-title":"EMBO Mol. Med."},{"key":"62673_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52757-w","volume":"15","author":"TA Kluiver","year":"2024","unstructured":"Kluiver, T. A. et al. Divergent WNT signaling and drug sensitivity profiles within hepatoblastoma tumors and organoids. Nat. Commun. 15, 8576 (2024).","journal-title":"Nat. Commun."},{"key":"62673_CR23","doi-asserted-by":"publisher","first-page":"eadq1724","DOI":"10.1126\/sciadv.adq1724","volume":"11","author":"SY Kim","year":"2025","unstructured":"Kim, S. Y. et al. Organoid drug profiling identifies methotrexate as a therapy for SCCOHT, a rare pediatric cancer. Sci. Adv. 11, eadq1724 (2025).","journal-title":"Sci. Adv."},{"key":"62673_CR24","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1038\/s41388-023-02681-y","volume":"42","author":"I Paassen","year":"2023","unstructured":"Paassen, I. et al. Atypical teratoid\/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities. Oncogene 42, 1661\u20131671 (2023).","journal-title":"Oncogene"},{"key":"62673_CR25","doi-asserted-by":"publisher","unstructured":"Kim, S.-Y., van de Wetering, M., Clevers, H. & Sanders, K. The future of tumor organoids in precision therapy. Trends Cancer. https:\/\/doi.org\/10.1016\/j.trecan.2025.03.005 (2025).","DOI":"10.1016\/j.trecan.2025.03.005"},{"key":"62673_CR26","doi-asserted-by":"publisher","first-page":"26580","DOI":"10.1073\/pnas.1911273116","volume":"116","author":"E Driehuis","year":"2019","unstructured":"Driehuis, E. et al. Pancreatic cancer organoids recapitulate disease and allow personalized drug screening. Proc. Natl. Acad. Sci. USA 116, 26580\u201326590 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62673_CR27","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1126\/science.aao2774","volume":"359","author":"G Vlachogiannis","year":"2018","unstructured":"Vlachogiannis, G. et al. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science 359, 920\u2013926 (2018).","journal-title":"Science"},{"key":"62673_CR28","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1158\/2159-8290.CD-18-1522","volume":"9","author":"E Driehuis","year":"2019","unstructured":"Driehuis, E. et al. Oral mucosal organoids as a potential platform for personalized cancer therapy. Cancer Discov. 9, 852\u2013871 (2019).","journal-title":"Cancer Discov."},{"key":"62673_CR29","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1038\/s41591-019-0584-2","volume":"25","author":"K Ganesh","year":"2019","unstructured":"Ganesh, K. et al. A rectal cancer organoid platform to study individual responses to chemoradiation. Nat. Med. 25, 1607\u20131614 (2019).","journal-title":"Nat. Med."},{"key":"62673_CR30","doi-asserted-by":"publisher","first-page":"eaay2574","DOI":"10.1126\/scitranslmed.aay2574","volume":"11","author":"SN Ooft","year":"2019","unstructured":"Ooft, S. N. et al. Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients. Sci. Transl. Med. 11, eaay2574 (2019).","journal-title":"Sci. Transl. Med."},{"key":"62673_CR31","doi-asserted-by":"publisher","first-page":"101335","DOI":"10.1016\/j.xcrm.2023.101335","volume":"4","author":"T Tan","year":"2023","unstructured":"Tan, T. et al. Unified framework for patient-derived, tumor-organoid-based predictive testing of standard-of-care therapies in metastatic colorectal cancer. Cell Rep. Med. 4, 101335 (2023).","journal-title":"Cell Rep. Med."},{"key":"62673_CR32","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.stem.2016.04.003","volume":"18","author":"M Fujii","year":"2016","unstructured":"Fujii, M. et al. A colorectal tumor organoid library demonstrates progressive loss of niche factor requirements during tumorigenesis. Cell Stem Cell 18, 827\u2013838 (2016).","journal-title":"Cell Stem Cell"},{"key":"62673_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02677-2","volume":"19","author":"L Liu","year":"2021","unstructured":"Liu, L., Yu, L., Li, Z., Li, W. & Huang, W. Patient-derived organoid (PDO) platforms to facilitate clinical decision making. J. Transl. Med. 19, 40 (2021).","journal-title":"J. Transl. Med."},{"key":"62673_CR34","doi-asserted-by":"publisher","first-page":"100095","DOI":"10.1016\/j.xgen.2022.100095","volume":"2","author":"CK Hirt","year":"2022","unstructured":"Hirt, C. K. et al. Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label treatment. Cell Genom. 2, 100095 (2022).","journal-title":"Cell Genom."},{"key":"62673_CR35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/pin.13293","volume":"73","author":"A Yoshida","year":"2023","unstructured":"Yoshida, A. Ewing and Ewing-like sarcomas: a morphological guide through genetically-defined entities. Pathol. Int 73, 12\u201326 (2023).","journal-title":"Pathol. Int"},{"key":"62673_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/path.5053","volume":"245","author":"S Watson","year":"2018","unstructured":"Watson, S. et al. Transcriptomic definition of molecular subgroups of small round cell sarcomas. J. Pathol. 245, 29\u201340 (2018).","journal-title":"J. Pathol."},{"key":"62673_CR37","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/gcc.22828","volume":"59","author":"Y Tsuda","year":"2020","unstructured":"Tsuda, Y. et al. Ewing sarcoma with FEV gene rearrangements is a rare subset with predilection for extraskeletal locations and aggressive behavior. Genes Chromosomes Cancer 59, 286\u2013294 (2020).","journal-title":"Genes Chromosomes Cancer"},{"key":"62673_CR38","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/modpathol.2016.140","volume":"29","author":"YP Hung","year":"2016","unstructured":"Hung, Y. P., Fletcher, C. D. & Hornick, J. L. Evaluation of ETV4 and WT1 expression in CIC-rearranged sarcomas and histologic mimics. Mod. Pathol. 29, 1324\u20131334 (2016).","journal-title":"Mod. Pathol."},{"key":"62673_CR39","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1158\/2159-8290.CD-13-1037","volume":"4","author":"BD Crompton","year":"2014","unstructured":"Crompton, B. D. et al. The genomic landscape of pediatric Ewing sarcoma. Cancer Discov. 4, 1326\u20131341 (2014).","journal-title":"Cancer Discov."},{"key":"62673_CR40","doi-asserted-by":"publisher","first-page":"e1004475","DOI":"10.1371\/journal.pgen.1004475","volume":"10","author":"AS Brohl","year":"2014","unstructured":"Brohl, A. S. et al. The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation. PLoS Genet. 10, e1004475 (2014).","journal-title":"PLoS Genet."},{"key":"62673_CR41","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/ng.3363","volume":"47","author":"TG Gr\u00fcnewald","year":"2015","unstructured":"Gr\u00fcnewald, T. G. et al. Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite. Nat. Genet. 47, 1073\u20131078 (2015).","journal-title":"Nat. Genet."},{"key":"62673_CR42","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3390\/jpm13050730","volume":"13","author":"AI Riskjell","year":"2023","unstructured":"Riskjell, A. I., Makinen, V. N., Sandfeld-Paulsen, B. & Aggerholm-Pedersen, N. Targeted treatment of soft-tissue sarcoma. J. Personal. Med. 13, 730 (2023).","journal-title":"J. Personal. Med."},{"key":"62673_CR43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/modpathol.2014.83","volume":"28","author":"SC Smith","year":"2015","unstructured":"Smith, S. C. et al. CIC-DUX sarcomas demonstrate frequent MYC amplification and ETS-family transcription factor expression. Mod. Pathol. 28, 57\u201368 (2015).","journal-title":"Mod. Pathol."},{"key":"62673_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s13569-019-0122-5","volume":"9","author":"NQ Bui","year":"2019","unstructured":"Bui, N. Q. et al. A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis. Clin. Sarcoma Res. 9, 12 (2019).","journal-title":"Clin. Sarcoma Res."},{"key":"62673_CR45","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.ygyno.2020.02.024","volume":"157","author":"DI Lin","year":"2020","unstructured":"Lin, D. I. et al. Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss. Gynecol. Oncol. 157, 357\u2013366 (2020).","journal-title":"Gynecol. Oncol."},{"key":"62673_CR46","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/cncr.31919","volume":"125","author":"KX Liu","year":"2019","unstructured":"Liu, K. X. et al. Risk stratification by somatic mutation burden in Ewing sarcoma. Cancer 125, 1357\u20131364 (2019).","journal-title":"Cancer"},{"key":"62673_CR47","doi-asserted-by":"publisher","first-page":"D1210","DOI":"10.1093\/nar\/gkad986","volume":"52","author":"Z Sondka","year":"2024","unstructured":"Sondka, Z. et al. COSMIC: a curated database of somatic variants and clinical data for cancer. Nucleic Acids Res. 52, D1210\u2013D1217 (2024).","journal-title":"Nucleic Acids Res."},{"key":"62673_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1842-9","volume":"20","author":"BJ Haas","year":"2019","unstructured":"Haas, B. J. et al. Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods. Genome Biol. 20, 213 (2019).","journal-title":"Genome Biol."},{"key":"62673_CR49","doi-asserted-by":"publisher","first-page":"100511","DOI":"10.1016\/j.modpat.2024.100511","volume":"37","author":"S Doll","year":"2024","unstructured":"Doll, S. et al. Proteomic characterization of undifferentiated small round cell sarcomas with EWSR1 and CIC::DUX4 translocations reveals diverging tumor biology and distinct diagnostic markers. Mod. Pathol. 37, 100511 (2024).","journal-title":"Mod. Pathol."},{"key":"62673_CR50","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1038\/emboj.2010.106","volume":"29","author":"GH Wei","year":"2010","unstructured":"Wei, G. H. et al. Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo. EMBO J. 29, 2147\u20132160 (2010).","journal-title":"EMBO J."},{"key":"62673_CR51","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ccell.2014.10.004","volume":"26","author":"N Riggi","year":"2014","unstructured":"Riggi, N. et al. EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma. Cancer Cell 26, 668\u2013681 (2014).","journal-title":"Cancer Cell"},{"key":"62673_CR52","doi-asserted-by":"publisher","first-page":"20776","DOI":"10.1073\/pnas.2009137117","volume":"117","author":"YK Lin","year":"2020","unstructured":"Lin, Y. K., Wu, W., Ponce, R. K., Kim, J. W. & Okimoto, R. A. Negative MAPK-ERK regulation sustains CIC-DUX4 oncoprotein expression in undifferentiated sarcoma. Proc. Natl. Acad. Sci. USA 117, 20776\u201320784 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62673_CR53","doi-asserted-by":"publisher","first-page":"D882","DOI":"10.1093\/nar\/gkz1062","volume":"48","author":"Y Luo","year":"2020","unstructured":"Luo, Y. et al. New developments on the Encyclopedia of DNA Elements (ENCODE) data portal. Nucleic Acids Res. 48, D882\u2013d889 (2020).","journal-title":"Nucleic Acids Res."},{"key":"62673_CR54","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1158\/0008-5472.CAN-04-2857","volume":"65","author":"S Hu-Lieskovan","year":"2005","unstructured":"Hu-Lieskovan, S. et al. EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing\u2019s family of tumors. Cancer Res. 65, 4633\u20134644 (2005).","journal-title":"Cancer Res."},{"key":"62673_CR55","first-page":"96","volume":"1785","author":"BT McGrogan","year":"2008","unstructured":"McGrogan, B. T., Gilmartin, B., Carney, D. N. & McCann, A. Taxanes, microtubules and chemoresistant breast cancer. Biochim. Biophys. Acta 1785, 96\u2013132 (2008).","journal-title":"Biochim. Biophys. Acta"},{"key":"62673_CR56","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.celrep.2017.01.031","volume":"18","author":"B Wang","year":"2017","unstructured":"Wang, B. et al. ATXN1L, CIC, and ETS transcription factors modulate sensitivity to MAPK pathway inhibition. Cell Rep. 18, 1543\u20131557 (2017).","journal-title":"Cell Rep."},{"key":"62673_CR57","first-page":"12","volume":"23","author":"X-Y Hua","year":"2021","unstructured":"Hua, X.-Y., Bie, X.-X., Cheng, X. & Zhang, S.-G. High expression of CIN85 promotes proliferation and invasion of human esophageal squamous cell carcinoma. Mol. Med. Rep. 23, 12 (2021).","journal-title":"Mol. Med. Rep."},{"key":"62673_CR58","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1200\/JCO.2014.59.5256","volume":"33","author":"N Gaspar","year":"2015","unstructured":"Gaspar, N. et al. Ewing sarcoma: current management and future approaches through collaboration. J. Clin. Oncol. 33, 3036\u20133046 (2015).","journal-title":"J. Clin. Oncol."},{"key":"62673_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/2045-3329-2-12","volume":"2","author":"J Whelan","year":"2012","unstructured":"Whelan, J. et al. Interval compressed vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide, etoposide in patients with advanced Ewing\u2019s and other small round cell sarcomas. Clin. Sarcoma Res 2, 12 (2012).","journal-title":"Clin. Sarcoma Res"},{"key":"62673_CR60","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1002\/cam4.4580","volume":"11","author":"EA Connolly","year":"2022","unstructured":"Connolly, E. A. et al. Systemic treatments and outcomes in CIC-rearranged Sarcoma: a national multi-centre clinicopathological series and literature review. Cancer Med. 11, 1805\u20131816 (2022).","journal-title":"Cancer Med."},{"key":"62673_CR61","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1097\/PAS.0000000000000846","volume":"41","author":"CR Antonescu","year":"2017","unstructured":"Antonescu, C. R. et al. Sarcomas With CIC-rearrangements are a distinct pathologic entity with aggressive outcome: a clinicopathologic and molecular study of 115 cases. Am. J. Surg. Pathol. 41, 941\u2013949 (2017).","journal-title":"Am. J. Surg. Pathol."},{"key":"62673_CR62","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s00432-024-05631-7","volume":"150","author":"J Murphy","year":"2024","unstructured":"Murphy, J. et al. Clinical outcomes of patients with CIC-rearranged sarcoma: a single institution retrospective analysis. J. Cancer Res. Clin. Oncol. 150, 112 (2024).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"62673_CR63","doi-asserted-by":"publisher","first-page":"7275","DOI":"10.1128\/MCB.24.16.7275-7283.2004","volume":"24","author":"A Prieur","year":"2004","unstructured":"Prieur, A., Tirode, F., Cohen, P. & Delattre, O. EWS\/FLI-1 silencing and gene profiling of ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3. Mol. Cell. Biol. 24, 7275\u20137283 (2004).","journal-title":"Mol. Cell. Biol."},{"key":"62673_CR64","doi-asserted-by":"publisher","first-page":"9282","DOI":"10.1038\/sj.onc.1207081","volume":"22","author":"S Mateo-Lozano","year":"2003","unstructured":"Mateo-Lozano, S., Tirado, O. M. & Notario, V. Rapamycin induces the fusion-type independent downregulation of the EWS\/FLI-1 proteins and inhibits Ewing\u2019s sarcoma cell proliferation. Oncogene 22, 9282\u20139287 (2003).","journal-title":"Oncogene"},{"key":"62673_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04967-0","volume":"7","author":"R Oyama","year":"2017","unstructured":"Oyama, R. et al. Generation of novel patient-derived CIC-DUX4 sarcoma xenografts and cell lines. Sci. Rep. 7, 4712 (2017).","journal-title":"Sci. Rep."},{"key":"62673_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-52143-3","volume":"9","author":"S Nakai","year":"2019","unstructured":"Nakai, S. et al. Establishment of a novel human CIC-DUX(4) sarcoma cell line, Kitra-SRS, with autocrine IGF-1R activation and metastatic potential to the lungs. Sci. Rep. 9, 15812 (2019).","journal-title":"Sci. Rep."},{"key":"62673_CR67","doi-asserted-by":"publisher","first-page":"106651","DOI":"10.1016\/j.isci.2023.106651","volume":"26","author":"R Fevre","year":"2023","unstructured":"Fevre, R. et al. Combinatorial drug screening on 3D Ewing sarcoma spheroids using droplet-based microfluidics. iScience 26, 106651 (2023).","journal-title":"iScience"},{"key":"62673_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-56985-4","volume":"14","author":"A Nitsch","year":"2024","unstructured":"Nitsch, A. et al. Effective combination of cold physical plasma and chemotherapy against Ewing sarcoma cells in vitro. Sci. Rep. 14, 6505 (2024).","journal-title":"Sci. Rep."},{"key":"62673_CR69","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s43018-022-00337-6","volume":"3","author":"KP Guillen","year":"2022","unstructured":"Guillen, K. P. et al. A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology. Nat. Cancer 3, 232\u2013250 (2022).","journal-title":"Nat. Cancer"},{"key":"62673_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21300-6","volume":"12","author":"S Karkampouna","year":"2021","unstructured":"Karkampouna, S. et al. Patient-derived xenografts and organoids model therapy response in prostate cancer. Nat. Commun. 12, 1117 (2021).","journal-title":"Nat. Commun."},{"key":"62673_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11434-9","volume":"23","author":"J Gao","year":"2023","unstructured":"Gao, J. et al. Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challenges. BMC Cancer 23, 1205 (2023).","journal-title":"BMC Cancer"},{"key":"62673_CR72","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41580-020-0259-3","volume":"21","author":"J Kim","year":"2020","unstructured":"Kim, J., Koo, B.-K. & Knoblich, J. A. Human organoids: model systems for human biology and medicine. Nat. Rev. Mol. Cell Biol. 21, 571\u2013584 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"62673_CR73","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.cancergencyto.2003.08.014","volume":"150","author":"A Ohali","year":"2004","unstructured":"Ohali, A. et al. High frequency of genomic instability in Ewing family of tumors. Cancer Genet. Cytogenet. 150, 50\u201356 (2004).","journal-title":"Cancer Genet. Cytogenet."},{"key":"62673_CR74","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41416-021-01438-2","volume":"125","author":"DL Casey","year":"2021","unstructured":"Casey, D. L. et al. TP53 mutations increase radioresistance in rhabdomyosarcoma and Ewing sarcoma. Br. J. Cancer 125, 576\u2013581 (2021).","journal-title":"Br. J. Cancer"},{"key":"62673_CR75","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.humpath.2016.09.004","volume":"58","author":"L Lazo de la Vega","year":"2016","unstructured":"Lazo de la Vega, L. et al. Targeted next-generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p loss. Hum. Pathol. 58, 161\u2013170 (2016).","journal-title":"Hum. Pathol."},{"key":"62673_CR76","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41586-018-0024-3","volume":"556","author":"SF Roerink","year":"2018","unstructured":"Roerink, S. F. et al. Intra-tumour diversification in colorectal cancer at the single-cell level. Nature 556, 457\u2013462 (2018).","journal-title":"Nature"},{"key":"62673_CR77","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1038\/s41416-023-02413-9","volume":"129","author":"F Duffaud","year":"2023","unstructured":"Duffaud, F. et al. Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study. Br. J. Cancer 129, 1940\u20131948 (2023).","journal-title":"Br. J. Cancer"},{"key":"62673_CR78","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.cmet.2017.09.009","volume":"26","author":"KM Lee","year":"2017","unstructured":"Lee, K. M. et al. MYC and MCL1 cooperatively promote chemotherapy-resistant breast cancer stem cells via regulation of mitochondrial oxidative phosphorylation. Cell Metab. 26, 633\u2013647.e637 (2017).","journal-title":"Cell Metab."},{"key":"62673_CR79","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s43856-023-00380-z","volume":"3","author":"J Yuda","year":"2023","unstructured":"Yuda, J. et al. Selective MCL-1 inhibitor ABBV-467 is efficacious in tumor models but is associated with cardiac troponin increases in patients. Commun. Med. 3, 154 (2023).","journal-title":"Commun. Med."},{"key":"62673_CR80","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1101\/gad.215855.113","volume":"27","author":"X Wang","year":"2013","unstructured":"Wang, X. et al. Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunction. Genes Dev. 27, 1351\u20131364 (2013).","journal-title":"Genes Dev."},{"key":"62673_CR81","doi-asserted-by":"publisher","first-page":"216028","DOI":"10.1016\/j.canlet.2022.216028","volume":"554","author":"S Grissenberger","year":"2023","unstructured":"Grissenberger, S. et al. High-content drug screening in zebrafish xenografts reveals high efficacy of dual MCL-1\/BCL-XL inhibition against Ewing sarcoma. Cancer Lett. 554, 216028 (2023).","journal-title":"Cancer Lett."},{"key":"62673_CR82","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1093\/nar\/gkw520","volume":"44","author":"R Shen","year":"2016","unstructured":"Shen, R. & Seshan, V. E. FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing. Nucleic Acids Res. 44, e131 (2016).","journal-title":"Nucleic Acids Res."},{"key":"62673_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-020-03919-2","volume":"21","author":"S Gillis","year":"2020","unstructured":"Gillis, S. & Roth, A. PyClone-VI: scalable inference of clonal population structures using whole genome data. BMC Bioinform. 21, 571 (2020).","journal-title":"BMC Bioinform."},{"key":"62673_CR84","doi-asserted-by":"publisher","first-page":"e2000504","DOI":"10.1200\/PO.20.00504","volume":"6","author":"JY Hehir-Kwa","year":"2022","unstructured":"Hehir-Kwa, J. Y. et al. Improved gene fusion detection in childhood cancer diagnostics using RNA sequencing. JCO Precis Oncol. 6, e2000504 (2022).","journal-title":"JCO Precis Oncol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62673-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62673-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62673-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T08:25:45Z","timestamp":1757406345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62673-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["62673"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-62673-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5039845\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"5 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.C. is an inventor on patents held by the Royal Netherlands Academy of Arts and Sciences that cover organoid technology. He is now head of Pharma Research and Early Development (pRED) at Roche, Basel, Switzerland. H.C.\u2019s full disclosure is given at\n                      \n                      . All other authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7689"}}